메뉴 건너뛰기




Volumn 113, Issue 3, 2009, Pages 335-340

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study

Author keywords

HIPEC; Ovarian cancer; Oxaliplatin; Recurrence; Secondary cytoreduction

Indexed keywords

DOCETAXEL; OXALIPLATIN; PLATINUM;

EID: 67349248443     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.004     Document Type: Article
Times cited : (56)

References (37)
  • 1
    • 0029802958 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)
    • McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., Clarke-Pearson D.L., and Davidson M. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin. Oncol. 23 5 Suppl 12 (1996) 40-47
    • (1996) Semin. Oncol. , vol.23 , Issue.5 SUPPL. 12 , pp. 40-47
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3    Kucera, P.R.4    Partridge, E.E.5    Look, K.Y.6    Clarke-Pearson, D.L.7    Davidson, M.8
  • 2
    • 0033986363 scopus 로고    scopus 로고
    • Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a Gynecologic Oncology Group study
    • Muggia F.M., Braly P.S., Brady M.F., Sutton G., Niemann T.H., Lentz S.L., Alvarez R.D., Kucera P.R., and Small J.M. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a Gynecologic Oncology Group study. J. Clin Oncol. 18 (2000) 106-115
    • (2000) J. Clin Oncol. , vol.18 , pp. 106-115
    • Muggia, F.M.1    Braly, P.S.2    Brady, M.F.3    Sutton, G.4    Niemann, T.H.5    Lentz, S.L.6    Alvarez, R.D.7    Kucera, P.R.8    Small, J.M.9
  • 3
    • 0141688377 scopus 로고    scopus 로고
    • Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study
    • Gynecologic Oncology Group
    • Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., Mannel R.S., deGeest K., Hartenbach E.M., Baergen R., and Gynecologic Oncology Group. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J. Clin Oncol. 21 (2003) 3194-3200
    • (2003) J. Clin Oncol. , vol.21 , pp. 3194-3200
    • Ozols, R.F.1    Bundy, B.N.2    Greer, B.E.3    Fowler, J.M.4    Clarke-Pearson, D.5    Burger, R.A.6    Mannel, R.S.7    deGeest, K.8    Hartenbach, E.M.9    Baergen, R.10
  • 4
    • 0026634982 scopus 로고
    • Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
    • [see comment, erratum appears in J Clin Oncol 1992 Sep;10:1505]
    • Alberts D.S., Green S., Hannigan E.V., O'Toole R., Stock-Novack D., Anderson P., Surwit E.A., Malvlya V.K., Nahhas W.A., and Jolles C.J. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J. Clin Oncol. 10 (1992) 706-717 [see comment, erratum appears in J Clin Oncol 1992 Sep;10:1505]
    • (1992) J. Clin Oncol. , vol.10 , pp. 706-717
    • Alberts, D.S.1    Green, S.2    Hannigan, E.V.3    O'Toole, R.4    Stock-Novack, D.5    Anderson, P.6    Surwit, E.A.7    Malvlya, V.K.8    Nahhas, W.A.9    Jolles, C.J.10
  • 5
    • 28044470530 scopus 로고    scopus 로고
    • Secondary cytoreduction for patients with recurrent ovarian cancer
    • Díaz-Montes T.P., and Bristow R.E. Secondary cytoreduction for patients with recurrent ovarian cancer. Curr. Oncol. Rep. 7 6 (2005) 451-458
    • (2005) Curr. Oncol. Rep. , vol.7 , Issue.6 , pp. 451-458
    • Díaz-Montes, T.P.1    Bristow, R.E.2
  • 7
    • 0018926727 scopus 로고
    • Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats
    • Shiu M.H., and Fortner J.G. Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res. 40 (1980) 4081-4084
    • (1980) Cancer Res. , vol.40 , pp. 4081-4084
    • Shiu, M.H.1    Fortner, J.G.2
  • 8
    • 0026568877 scopus 로고
    • Hyperthermia in cancer growth regulation
    • Vernon C. Hyperthermia in cancer growth regulation. Biotherapy 4 (1992) 307-315
    • (1992) Biotherapy , vol.4 , pp. 307-315
    • Vernon, C.1
  • 9
    • 0027990529 scopus 로고
    • Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum (II)
    • Akaboshi M., Tanaka Y., Kawai K., Akuta K., Masunaga S., and Ono K. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum (II). Int. J. Radiat. Biol. 66 (1994) 215-220
    • (1994) Int. J. Radiat. Biol. , vol.66 , pp. 215-220
    • Akaboshi, M.1    Tanaka, Y.2    Kawai, K.3    Akuta, K.4    Masunaga, S.5    Ono, K.6
  • 10
    • 0031040248 scopus 로고    scopus 로고
    • Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
    • Fujimoto S., Takahashi M., Mutou T., Kobayashi K., Toyosawa T., and Ohkubo H. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79 (1997) 884-891
    • (1997) Cancer , vol.79 , pp. 884-891
    • Fujimoto, S.1    Takahashi, M.2    Mutou, T.3    Kobayashi, K.4    Toyosawa, T.5    Ohkubo, H.6
  • 12
    • 0033386774 scopus 로고    scopus 로고
    • Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy
    • Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann. Surg. Oncol. 6 (1999) 727-731
    • (1999) Ann. Surg. Oncol. , vol.6 , pp. 727-731
    • Sugarbaker, P.H.1    Chang, D.2
  • 13
    • 0035037302 scopus 로고    scopus 로고
    • Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin
    • Witkamp A.J., De Bree E., Kaag M.M., boot H., Beijnen J.H., van Slooten G.W., van Coevorden F., and Zoetmulder F.A. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur. J. Cancer 37 (2001) 979-984
    • (2001) Eur. J. Cancer , vol.37 , pp. 979-984
    • Witkamp, A.J.1    De Bree, E.2    Kaag, M.M.3    boot, H.4    Beijnen, J.H.5    van Slooten, G.W.6    van Coevorden, F.7    Zoetmulder, F.A.8
  • 14
    • 0034935417 scopus 로고    scopus 로고
    • Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study
    • Deraco M., Rossi C.R., Pennacchioli E., Guadagni S., Somers D.C., santoro N., raspagliesi F., Kusamura S., and Vaglini M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 7 (2001) 120-126
    • (2001) Tumori , vol.7 , pp. 120-126
    • Deraco, M.1    Rossi, C.R.2    Pennacchioli, E.3    Guadagni, S.4    Somers, D.C.5    santoro, N.6    raspagliesi, F.7    Kusamura, S.8    Vaglini, M.9
  • 15
    • 0036330323 scopus 로고    scopus 로고
    • Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy
    • Panteix G., Beaujard A., Garbit F., Chaduiron-Faye C., Guillamont M., Gilly F., Baltassat P., and Bressolle F. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy. Anticancer Res. 22 (2002) 1329-1336
    • (2002) Anticancer Res. , vol.22 , pp. 1329-1336
    • Panteix, G.1    Beaujard, A.2    Garbit, F.3    Chaduiron-Faye, C.4    Guillamont, M.5    Gilly, F.6    Baltassat, P.7    Bressolle, F.8
  • 16
    • 33846879021 scopus 로고    scopus 로고
    • Secondary surgical cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent ovarian and endometrial cancer
    • Helm C.W., Martin R.S., Metzinger D.S., and Edwards R.P. Secondary surgical cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent ovarian and endometrial cancer. Int. Gynecol. Cancer Soc. 14 Suppl 1 (2004) 167
    • (2004) Int. Gynecol. Cancer Soc. , vol.14 , Issue.SUPPL. 1 , pp. 167
    • Helm, C.W.1    Martin, R.S.2    Metzinger, D.S.3    Edwards, R.P.4
  • 18
    • 0034442802 scopus 로고    scopus 로고
    • Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer
    • Delaloge S., Laadem A., Taamma A., Chouaki N., Cvitkovic E., Pautier P., Misset J.L., and Lhommè C. Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer. Am. J. Clin Oncol. 23 6 (2000) 569-574
    • (2000) Am. J. Clin Oncol. , vol.23 , Issue.6 , pp. 569-574
    • Delaloge, S.1    Laadem, A.2    Taamma, A.3    Chouaki, N.4    Cvitkovic, E.5    Pautier, P.6    Misset, J.L.7    Lhommè, C.8
  • 20
    • 34548381800 scopus 로고    scopus 로고
    • HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin
    • Elias D., Pocard M., and Goere D. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat res. 134 (2007) 303-318
    • (2007) Cancer Treat res. , vol.134 , pp. 303-318
    • Elias, D.1    Pocard, M.2    Goere, D.3
  • 21
    • 9744223515 scopus 로고    scopus 로고
    • Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin chemotherapy for ovarian carcinoma
    • Vasey P.A., Jayson G.C., Gordon A., et al. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin chemotherapy for ovarian carcinoma. J. Natl. Cancer Inst. 96 22 (2004) 1682-1691
    • (2004) J. Natl. Cancer Inst. , vol.96 , Issue.22 , pp. 1682-1691
    • Vasey, P.A.1    Jayson, G.C.2    Gordon, A.3
  • 23
    • 52649180066 scopus 로고    scopus 로고
    • A treatment selection protocol for recurrent ovarian cancer patients: the role of fdg-pet/ct and staging laparoscopy
    • Fagotti A., Fanfani F., Rossitto C., Lorusso D., De gaetano A.M., Giordano A., Vizzielli G., and Scambia G. A treatment selection protocol for recurrent ovarian cancer patients: the role of fdg-pet/ct and staging laparoscopy. Oncology 75 3-4 (2008) 152-158
    • (2008) Oncology , vol.75 , Issue.3-4 , pp. 152-158
    • Fagotti, A.1    Fanfani, F.2    Rossitto, C.3    Lorusso, D.4    De gaetano, A.M.5    Giordano, A.6    Vizzielli, G.7    Scambia, G.8
  • 24
    • 34547976092 scopus 로고    scopus 로고
    • Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
    • Bijelic L., Jonson A., and Sugarbaker P.H. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann. Oncol. 18 (2007) 1943-1950
    • (2007) Ann. Oncol. , vol.18 , pp. 1943-1950
    • Bijelic, L.1    Jonson, A.2    Sugarbaker, P.H.3
  • 25
    • 50849083213 scopus 로고    scopus 로고
    • Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy
    • Younan R., Kusamura S., Baratti D., and Cloutier AS e Deraco M. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J. Surg. Oncol. 98 (2008) 253-257
    • (2008) J. Surg. Oncol. , vol.98 , pp. 253-257
    • Younan, R.1    Kusamura, S.2    Baratti, D.3    Cloutier AS e Deraco, M.4
  • 26
    • 67349237351 scopus 로고    scopus 로고
    • National Cancer Institute. Cancer Therapy Evaluation Program: Common Toxicity Criteria. Version 2.0 1999;, 20 April 1999, date last accessed
    • National Cancer Institute. Cancer Therapy Evaluation Program: Common Toxicity Criteria. Version 2.0 1999; http://ctep.info.nih.gov (20 April 1999, date last accessed).
  • 27
    • 0036787775 scopus 로고    scopus 로고
    • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
    • Rizzo J.D., Lightin A.E., Woolf S.H., et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J. Clin Oncol. 10 (2002) 4083-4107
    • (2002) J. Clin Oncol. , vol.10 , pp. 4083-4107
    • Rizzo, J.D.1    Lightin, A.E.2    Woolf, S.H.3
  • 28
    • 33748093563 scopus 로고    scopus 로고
    • Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations
    • Ferrandina G., Legge F., Salutari V., Paglia A., Testa A., and Scambia G. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations. Eur. J. Cancer 42 (2006) 2296-2302
    • (2006) Eur. J. Cancer , vol.42 , pp. 2296-2302
    • Ferrandina, G.1    Legge, F.2    Salutari, V.3    Paglia, A.4    Testa, A.5    Scambia, G.6
  • 30
    • 50849103065 scopus 로고    scopus 로고
    • The intraoperative staging systems in the management of peritoneal surface malignancy
    • Portilla A.G., Shigeki K., Dario B., and Deraco M. The intraoperative staging systems in the management of peritoneal surface malignancy. J. Surg. Oncol. 98 (2008) 228-231
    • (2008) J. Surg. Oncol. , vol.98 , pp. 228-231
    • Portilla, A.G.1    Shigeki, K.2    Dario, B.3    Deraco, M.4
  • 31
    • 50849119765 scopus 로고    scopus 로고
    • Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    • Helm C.W., Bristow R.E., Kusamura S., Baratti D., and Deraco M. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J. Surg. Oncol. 98 (2008) 283-290
    • (2008) J. Surg. Oncol. , vol.98 , pp. 283-290
    • Helm, C.W.1    Bristow, R.E.2    Kusamura, S.3    Baratti, D.4    Deraco, M.5
  • 32
    • 33845657404 scopus 로고    scopus 로고
    • Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
    • Harter P., Du Bois A., Hahmann M., et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann. Surg. Oncol. 13 (2006) 1702-1710
    • (2006) Ann. Surg. Oncol. , vol.13 , pp. 1702-1710
    • Harter, P.1    Du Bois, A.2    Hahmann, M.3
  • 33
    • 57649083923 scopus 로고    scopus 로고
    • Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
    • Bristow R.E., Puri I., and Chi D.S. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol. Oncol. 112 (2009) 265-274
    • (2009) Gynecol. Oncol. , vol.112 , pp. 265-274
    • Bristow, R.E.1    Puri, I.2    Chi, D.S.3
  • 34
    • 19744365355 scopus 로고    scopus 로고
    • Secondary surgical cytoreduction for advanced ovarian carcinoma
    • Rose P.G., Nerenstone S., Brady M.F., et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N. Engl. J. Med. 351 (2004) 2489-2497
    • (2004) N. Engl. J. Med. , vol.351 , pp. 2489-2497
    • Rose, P.G.1    Nerenstone, S.2    Brady, M.F.3
  • 35
    • 17444426347 scopus 로고    scopus 로고
    • Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
    • Onda T., Yoshikawa H., Yasugi T., Yamada M., Matsumoto K., and Taketani Y. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br. J. Cancer 92 (2005) 1026-1032
    • (2005) Br. J. Cancer , vol.92 , pp. 1026-1032
    • Onda, T.1    Yoshikawa, H.2    Yasugi, T.3    Yamada, M.4    Matsumoto, K.5    Taketani, Y.6
  • 36
    • 40649114011 scopus 로고    scopus 로고
    • Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis
    • Ceelen W.P., Peeters M., Houtmeyers P., Breusegem C., De Somer F., and Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann. Surg. Oncol. 15 (2008) 535-541
    • (2008) Ann. Surg. Oncol. , vol.15 , pp. 535-541
    • Ceelen, W.P.1    Peeters, M.2    Houtmeyers, P.3    Breusegem, C.4    De Somer, F.5    Pattyn, P.6
  • 37
    • 4143087249 scopus 로고    scopus 로고
    • Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design
    • Markman M., Markman J., Webster K., Zanotti K., Kulp B., Peterson G., and Belinson J. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design. J. Clin Oncol. 22 (2004) 3120-3125
    • (2004) J. Clin Oncol. , vol.22 , pp. 3120-3125
    • Markman, M.1    Markman, J.2    Webster, K.3    Zanotti, K.4    Kulp, B.5    Peterson, G.6    Belinson, J.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.